ArticleNPJ breast cancer2017

Identification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancer.

Wei-Gang Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.